T 1356/21 (Long-acting formulations of insulins / SANOFI) of 05.10.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T135621.20231005
- Date of decision
- 5 October 2023
- Case number
- T 1356/21
- Petition for review of
- -
- Application number
- 11720115.2
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 054Abstract on EPC2000 Art 056
- Application title
- LONG - ACTING FORMULATIONS OF INSULINS
- Applicant name
- SANOFI
- Opponent name
- Cooke, Richard
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(5)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Late-filed evidence - admitted (no)
Novelty - selection invention (yes)
Inventive step - bonus effect (no) - Catchword
- 1. Novelty in the case of purpose-limited product claims pursuant to Article 54(5) EPC relying on a dosage regimen defined by a numerical range, see point 2.6 of the reasons.
2. Limits to the application of the concept of bonus effect, see point 3.4.3 of the reasons. - Cited cases
- G 0002/08T 0021/81T 0192/82T 0227/89T 0506/92T 0085/93T 1074/06T 0759/08T 1317/13T 0261/15T 1147/16
- Citing cases
- T 0295/22
Order
For these reasons it is decided that:
The appeal is dismissed.